Treatment of severe intermittent claudication with PGE1 a short-term vs a long-term infusion plan a 20-week, european randomized trial analysis of efficacy and costs

Angiology

Volumn 49, Issue 11, 1998, Pages 885-895

  Belcaro, G ^a   Laurora, G ^b   Nicolaides, A N ^b   Agus, G ^b   Cesarone, M R ^b   DeSanctis, M T ^b   Incandela, L ^b   Ricci, A ^b   Cazaubon, M ^b   Ippolito, E ^b   Barsotti, A ^b   Vasdekis, S ^b   Ledda, A ^b   Iacobitti, P ^b   Christopoulos, D ^b   Errichi, B M ^b   Helmis, H ^b   Cornelli, U ^b   Ramaswami, G ^b   Bucci, M ^b   Ferrari, P G ^b   Corsi, M ^b   Pomante, P ^b   Mezzanotte, L ^b   Cacchio, M ^b   Simeone, E ^b   Geroulakos, G ^b   more..

^a UNIVERSITY OF CHIETI   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALPROSTAR; PROSTAGLANDIN E1; PROSTAVASIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; DOSE RESPONSE; DRUG COST; DRUG EFFICACY; FEMALE; HUMAN; INJECTION PAIN; INTERMITTENT CLAUDICATION; INTRAVENOUS DRUG ADMINISTRATION; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; NAUSEA; PROSTAGLANDIN SYNTHESIS; VERTIGO;

EID: 15444353869     PISSN: 00033197     EISSN: None     Source Type: Journal    
DOI: 10.1177/000331979804901103     Document Type: Article

References (16)

1. Diehm C, Balzer K, Bisler H, et al: J Vase Surg 255:537-544, 1997.
2. European Working Group on Critical Leg Ischemia: Second European Consensus. Circulation 84 (suppl 4):1, 1991.
3. Coffmann JD: Intermittent claudication: Be conservative. N Engl J Med 325:577-578, 1991.
4. Ernst E, Fialka V: A review of the clinical effectiveness of exercise therapy for intermittent claudication. Arch Intern Med 153:2357-2360, 1993.
5. Pentecost MJ, Crisqui MH, Dorros G, et al: Guidelines for peripheral percutaneous transluminal angioplasty of the abdominal aorta and lower extremity vessels. Circulation 89:511-531, 1994.
6. 1 infusion in intermittent claudication. Vasa 17 (suppl):32-35, 1987.
7. 1 or intravenous pentoxyfylline during training. Circulation 90:818-822, 1994.
8. 1 infusion (data on file).
9. Patterson RB, Pinto B, Marcus B, et al: Value of supervised exercise program for the therapy of arterial claudication. J Vase Surg 25:312-319, 1997.
10. Heidrich H, Allanberg J, Cachovan M, et al: Guidelines for therapeutic studies on peripheral arterial occlusive disease in Fontaine stages II-IV. Vasa 21:339-343, 1992.
11. Cesarone MR: Good Clinical Practice. Le GCP. Istruzioni per l'uso. Norme pratiche per la ricerca clinica. Pescara, Cardiovascular Research Publishers, 1996.
12. Andriessen MPHM, Barendsen GJ, Wonda AA, et al: Changes of walking distance in patients with intermittent claudication during six months' intensive physical training. Vasa 18:63-68, 1989.
13. Lindgarde F, Jelnes R, Bjorkman H, et al: Conservative drug treatment in patients with moderately severe chronic occlusive peripheral arterial disease. Circulation 80:1549-1556, 1989.
14. 1-Wirkungen und Therapeutische Wirksamkeit, ed. by Heidrich H, Bohme H, Rogatti W. Berlin: Springer-Verlag, 1988, pp 103-111.
15. 1 infusion. Vasa 20 (suppl):215-217, 1987.
16. Mondani P: DRG/ROD nelle malattie Vascolari. Milan, Momento Medico, 1996.